Comorbidity and diagnosis distribution in transdiagnostic treatments for emotional disorders: A systematic review of randomized controlled trials
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: González-Robles, Alberto; Díaz-García, Amanda; Miguel Sanz, Clara; Díaz-García, Amanda; Botella, Cristina
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/8033
comunitat-uji-handle3:10234/8636
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Comorbidity and diagnosis distribution in transdiagnostic treatments for emotional disorders: A systematic review of randomized controlled trialsAutoria
Data de publicació
2018Editor
Public Library of ScienceISSN
1932-6203Cita bibliogràfica
: Gonza´lez-Robles A, Dı´az-Garcı´a A, Miguel C, Garcı´a-Palacios A, Botella C (2018) Comorbidity and diagnosis distribution in transdiagnostic treatments for emotional disorders: A systematic review of randomized controlled trials. PLoS ONE 13(11): e0207396. https://doi.org/10.1371/journal. pone.0207396Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0207396Versió
info:eu-repo/semantics/publishedVersionResum
The advantages of transdiagnostic protocols for emotional disorders (ED) (anxiety and
depression) include the ability to treat multiple psychological disorders using the same treatment protocol, and the capacity to ... [+]
The advantages of transdiagnostic protocols for emotional disorders (ED) (anxiety and
depression) include the ability to treat multiple psychological disorders using the same treatment protocol, and the capacity to better address comorbidity. Comorbidity in ED has been
associated with higher rates of severity, functional impairment, and chronicity. However, no
attempts have been made in the literature to systematically review whether these studies
include assessments to evaluate the treatment response in comorbid diagnoses, in addition
to the principal diagnosis. Moreover, transdiagnostic treatments have been developed for a
range of ED, but to date no study has analyzed the real distribution of diagnoses in these studies. The current study aimed to analyze: a) whether treatment response in comorbidity is evaluated in transdiagnostic treatments for ED; b) what diagnoses are targeted in transdiagnostic
treatments for ED; and c) the real distribution of the diagnoses at baseline in these studies. A
systematic search of the literature was conducted in PsycINFO, PubMed, EMBASE, and the
Cochrane Library. Fifty-two randomized controlled trials were identified, with a total of 7007
adult participants. The results showed that, although most of the studies reported data on
comorbidity at baseline, only 40% of them examined the effects of the intervention on the
comorbid disorders. The most commonly targeted diagnoses in transdiagnostic protocols
were panic/agoraphobia, generalized anxiety, social anxiety, and depression. Other disorders, such as obsessive-compulsive disorder, posttraumatic stress disorder, and anxiety/
depression not otherwise specified, were marginally included in these studies. Regarding the
distribution of diagnoses at baseline, generalized anxiety, panic/agoraphobia, social anxiety,
and depression were the most frequently observed, whereas depression not otherwise specified was the least represented. The results highlight the importance of assessing comorbidity
in addition to the principal diagnoses in transdiagnostic treatments, in order to draw conclusions about the true potential of these interventions to improve comorbid symptoms. Implications of the current study and directions for future research are discussed. [-]
Publicat a
PLoS ONE 13(11): e0207396Proyecto de investigación
FPU13/00576 ; PSI2014-54172-R ;Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- PSB_Articles [1291]
Els següents fitxers sobre la llicència estan associats a aquest element:
Except where otherwise noted, this item's license is described as © 2018 Gonza´lez-Robles et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.